Estrogen Receptor Gene Expression in Relation to Neuropsychiatric Disorders

Annals of the New York Academy of Sciences

Volumn 1007, Issue , 2003, Pages 54-63

  Östlund, Hanna ^a   Keller, Eva ^b   Hurd, Yasmin L ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Anatomical distribution; Depression; Estrogen receptor; Psychiatric disorders

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; NEUROTRANSMITTER; NORADRENALIN; RECEPTOR SUBTYPE; SEROTONIN 2A RECEPTOR;

AMYGDALOID NUCLEUS; BRAIN REGION; COGNITION; CONFERENCE PAPER; DEPRESSION; FOLLOW UP; GENE EXPRESSION; HUMAN; HYPOTHALAMUS; LOCUS CERULEUS; MEMORY; MENTAL DISEASE; MOOD; MOOD DISORDER; MOTOR PERFORMANCE; NEUROPATHOLOGY; NEUROPSYCHIATRY; NEUROTRANSMISSION; NONHUMAN; PROTEIN EXPRESSION; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM;

ANIMALIA;

EID: 1342302106     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1286.006     Document Type: Conference Paper

References (43)

1. PAYKEL, E.S. 1991. Depression in women. Br. J. Psychiatry. (Suppl. 10) 158: 22-29.
2. PEARLSTEIN, T., K. ROSEN & A.B. STONE. 1997. Mood disorders and menopause. Endocrinol. Metab. Clin. N. Am. 26: 279-294.
3. SICHEL, D.A., L.S. COHEN, L.M.A. ROBERTSON, et al. 1995. Prophylactic estrogen in recurrent postpartum affective disorder. Biol. Psychiatry 38: 814-818.
4. GREGOIRE, A.J.P., R. KUMAR, B. EVERITT, et al. 1996. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347: 930-933.
5. BEST, N., M. REES, D. BARLOW & P. COWEN. 1992. Effect of estradiol implant on noradrenergic function and mood in menopausal subjects. Psychoneuroendocrinology 17: 87-93.
6. HAFNER, H., A. REICHER-RÖSSLER, K. MAURER, et al. 1992. First onset and early symptomatology of schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 242: 109-118.
7. HAMBRECHT, M., K. MAURER & H. HÄFNER. 1992. Evidence for a gender bias in epidemiological studies of schizophrenia. Schizophr. Res. 8: 223-231.
8. GALDOS, P.M., J.J. VAN OS & R.M. MURRAY. 1993. Puberty and the onset of psychosis. Schizophr. Res. 10: 7-14.
9. FARAONE, S.V., W.J. CHEN, J.M. GOLDSTEIN & M.T. TSUANG. 1994. Gender differences in age at onset of schizophrenia. Br. J. Psychiatry 164: 625-629.
10. SZYMANSKI, S., J.A. LIEBERMAN, J.M. ALVIR, et al. 1995. Gender differences in onset of illness, treatment response, course, and biological indexes in first-episode schizophrenic patient. Am. J. Psychiatry 152: 698-703.
11. RIECHER-RÖSSLER, A. & H. HÄFNER. 1993. Schizophrenia and oestrogen - is there an association? Eur. Arch. Psychiatry Clin. Neurosci. 242: 323-328.
12. SEEMAN, M.V. 1986. Current outsome in schizophrenia: women vs men. Acta Psychiatric. Scand. 73: 609-617.
13. RIECHER-RÖSSLER, A., H. HAFNER, K. MAURER, et al. 1992. Schizophrenic symptomatology varies with serum estradiol levels during menstrual cycle. Schizophr. Res. 6: 114-115.
14. HALLONQUIST, J., M.V. SEEMAN, M. LANG & N.A. RECTOR. 1993. Variation in symptoms severity over the menstrual cycle of schizophrenics. Biol. Psychiatry 33: 207-209.
15. GATTAZ, W.F., P. VOGEL, A. RIECHERROSSLER & G. SODDU. 1994. Influence of the menstrual cycle phase on the therapeutic response in schizophrenia. Biol. Psychiatry 36: 137-139.
16. CARSON-JURICA, M.A., W.T. SCHRADER & B.W. O'MALLEY. 1990. Steroid receptor family: structure and functions. Endocr. Rev. 11: 201-220.
17. MANGELSDORF, D.J, C. THUMMEL, M. BEATO, et al. 1995. The nuclear receptor superfamily: the second decade. Cell 83: 835-839.
18. M.K. ÖSTERLUND & Y.L. HURD. 2001. Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog. Neurobiol. 64: 251-267.
19. OSTERLUND, M., J-Ý. GUSTAFSSON, E. KELLER & Y.L. HURD. 2000. Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERalpha mRNA. J. Clin. Endocrinol. Metab. 85: 3840-3846.
20. ÖSTERLUND, M.K., E. KELLER & Y.L. HURD. 2000. The human amygdaloid complex is characterized by high expression of the estrogen receptor mRNA. Neuroscience 95: 333-342.
21. ÖSTERLUND, M.K., K.E. GRANDIEN, E. KELLER & Y.L. HURD. 2000. The human brain has distinct regional expression patterns of estrogen receptor alpha mRNA isoforms derived from alternative promoters. J. Neurochem. 75: 1390-1397.
22. ÖSTERLUND, M.K. 2002. The role of estrogens in neuropsychiatric disorders. Curr. Opin. Psychiatry 15: 307-312.
23. GLOOR, P. 1997. The amygdaloid system. In The Temporal Lobe and Limbic System. P. Gloor, Ed.: 591-651. Oxford University Press. New York.
24. GRANDIEN, K. 1996. Determination of transcription start sites in the human estrogen receptor gene and identification of a novel, tissue-specific, estrogen receptor-mRNA isoform. Mol. Cell. Endocrinol. 116: 207-212.
25. FLOURIOT, G., C. GRIFFIN, M. KENEALY, et al. 1998. Differentially expressed messenger RNA isoforms of the human estrogen receptor-alpha gene are generated by alternative splicing and promoter usage. Mol. Endocrinol. 12: 1939-1954.
26. ÅSBERG, M., L. TRÄSKMAN & P. THOREN. 1976. 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor. Arch. Gen. Psychiatry 33: 1193-1197.
27. VAN PRAAG, H.M. 1983. Depression, suicide and the metabolites of serotonin in the brain. J. Affective Disord. 4: 275-290.
28. MELTZER, H.Y. & M.T. LOWY. 1987. The serotonin hypothesis of depression. In Psychopharmacology: The Third Generation of Progress. H.Y. Meltzer, Ed.: 513-526. Raven Press. New York.
29. MERSON, S. & P. TYRER. 1991. Physical treatments for depression. In Biological Aspects of Affective Disorders. R. Horton & C. Katona, Eds.: 47-68. Academic Press. San Diego, CA.
30. 2 receptor binding sites in depressed suicide victims. Brain Res. 443: 272-280.
31. 3H]ketanserin binding in the human brain postmortem: effect of suicide. Brain Res. 507: 208-215.
32. STANLEY, M. & J.J. MANN. 1983. Increased serotonin-2 binding site in frontal cortex of suicide victims. Lancet 1: 214-216.
33. 2 binding sites in the frontal cortex of suicide victims and control subjects. Am. J. Psychiatry 146: 730-736.
34. STOCKMEIER, C.A., G.E. DILLEY, B.S. SHAPIRO, et al. 1997. Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology 16: 162-173.
35. 2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br. J. Psychiatry 171: 444-448.
36. MATSUBARA, S., R.C. ARORA & H.Y. MELTZER. 1991. Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims. J. Neural Transm. Gen. Sect. 85: 181-194.
37. JOYCE, J.N., A. SHANE, N. LEXOW, et al. 1993. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 8: 315-336.
38. ARANGO, V., M.D. UNDERWOOD, A.D. GUBBI & J.J. MANN. 1995. Localized alterations in pre-and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 688: 121-133.
39. STOCKMEIER, C.A., B.S. SHAPIRO, G.E. DILLEY, et al. 1998. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J. Neurosci. 18: 7394-7401.
40. PECINS-THOMPSON, M. & C.L. BETHEA. 1999. Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques. Neuroscience 89: 267-277.
41. ÖSTERLUND, M., D.H. OVERSTREET & YL. HURD. 1999. The Flinders sensitive line rats, a genetic model of depression, show abnormal serotonin receptor mRNA expression in the brain that is reversed by 17β-estradiol. Brain Res. Mol. Brain Res. 10: 158-166.
42. HERBISON, A.E., S.X. SIMONIAN, N.R. THANKY & R.J. BICKNELL. 2000. Oestrogen modulation of noradrenaline neurotransmission [review]. Novartis Found. Symp. 230: 74-85; discussion 85-93.
43. HENRIKSSON, M.M., H.M. ARO, M J. MARTTUNEN, et al. 1993. Mental disorders and comorbidity in suicide. Am. J. Psychiatry 150: 935-940.